Elevance Health shares are trading lower after Wolfe Research downgraded the stock from Outperform to Peer Perform.
Portfolio Pulse from Benzinga Newsdesk
Elevance Health's stock has been downgraded from Outperform to Peer Perform by Wolfe Research, leading to a decrease in its share price.
July 12, 2023 | 5:04 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Elevance Health's stock was downgraded by Wolfe Research, which has resulted in a decrease in its share price.
The downgrade of Elevance Health's stock by Wolfe Research from Outperform to Peer Perform is a negative signal to investors, which has led to a decrease in the stock's price. This indicates a lack of confidence in the company's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100